Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.30 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.27, with a volume of 3,671,663 shares changing hands.
Northwest Biotherapeutics Price Performance
The firm has a market cap of $361.38 million, a P/E ratio of -3.36 and a beta of -0.51. The company has a fifty day moving average of $0.28 and a 200-day moving average of $0.30.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last posted its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $0.36 million for the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Articles
- Five stocks we like better than Northwest Biotherapeutics
- Using the MarketBeat Stock Split Calculator
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is diluted earnings per share (Diluted EPS)?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What Are the U.K. Market Holidays? How to Invest and Trade
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
